🇺🇸 FDA
Patent

US 8337853

Monoclonal antibodies that bind or neutralize dengue virus

granted A61KA61K2039/505A61P

Quick answer

US patent 8337853 (Monoclonal antibodies that bind or neutralize dengue virus) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/505, A61P, A61P31/12